Disseminated tumor cells in the bone marrow of patients with operable primary breast cancer: prognostic impact in immunophenotypic subgroups and clinical implication for bisphosphonate treatment

Background Disseminated tumor cells (DTC) in the bone marrow (BM) of primary breast cancer (BC) patients are a promising surrogate marker of micrometastatic spread and an independent predictor of poor prognosis for disease-free survival (DFS) and overall survival (OS). The present study aims to anal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Stefanovic, Stefan (VerfasserIn) , Diel, Ingo J. (VerfasserIn) , Sinn, Peter (VerfasserIn) , Englert, Stefan (VerfasserIn) , Hennigs, André (VerfasserIn) , Mayer, Christine (VerfasserIn) , Schott, Sarah (VerfasserIn) , Wallwiener, Markus (VerfasserIn) , Blumenstein, Maria (VerfasserIn) , Golatta, Michael (VerfasserIn) , Heil, Jörg (VerfasserIn) , Rom, Joachim (VerfasserIn) , Sohn, Christof (VerfasserIn) , Schneeweiss, Andreas (VerfasserIn) , Schütz, Florian (VerfasserIn) , Domschke, Christoph (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2016
In: Annals of surgical oncology
Year: 2016, Jahrgang: 23, Heft: 3, Pages: 757-766
ISSN:1534-4681
DOI:10.1245/s10434-015-4895-3
Online-Zugang:Verlag, Volltext: https://doi.org/10.1245/s10434-015-4895-3
Volltext
Verfasserangaben:Stefan Stefanovic, MD, Ingo Diel, MD, Peter Sinn, MD, Stefan Englert, PhD, Andre Hennigs, MD, Christine Mayer, MD, Sarah Schott, MD, Markus Wallwiener, MD, Maria Blumenstein, MD, Michael Golatta, MD, Joerg Heil, MD, Joachim Rom, MD, Christof Sohn, MD, Andreas Schneeweiss, MD, Florian Schuetz, MD, and Christoph Domschke, MD

MARC

LEADER 00000caa a2200000 c 4500
001 1666139009
003 DE-627
005 20240828092258.0
007 cr uuu---uuuuu
008 190522s2016 xx |||||o 00| ||eng c
024 7 |a 10.1245/s10434-015-4895-3  |2 doi 
035 |a (DE-627)1666139009 
035 |a (DE-599)KXP1666139009 
035 |a (OCoLC)1341225215 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Stefanovic, Stefan  |e VerfasserIn  |0 (DE-588)111256117X  |0 (DE-627)866525831  |0 (DE-576)476625564  |4 aut 
245 1 0 |a Disseminated tumor cells in the bone marrow of patients with operable primary breast cancer  |b prognostic impact in immunophenotypic subgroups and clinical implication for bisphosphonate treatment  |c Stefan Stefanovic, MD, Ingo Diel, MD, Peter Sinn, MD, Stefan Englert, PhD, Andre Hennigs, MD, Christine Mayer, MD, Sarah Schott, MD, Markus Wallwiener, MD, Maria Blumenstein, MD, Michael Golatta, MD, Joerg Heil, MD, Joachim Rom, MD, Christof Sohn, MD, Andreas Schneeweiss, MD, Florian Schuetz, MD, and Christoph Domschke, MD 
264 1 |c 2016 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a First online: 14 October 2015 
500 |a Gesehen am 22.05.2019 
520 |a Background Disseminated tumor cells (DTC) in the bone marrow (BM) of primary breast cancer (BC) patients are a promising surrogate marker of micrometastatic spread and an independent predictor of poor prognosis for disease-free survival (DFS) and overall survival (OS). The present study aims to analyze DTCs as an independent prognostic factor for DFS/OS in tumor biology and bisphosphonate treatment.MethodsA total of 504 patients with operable primary BC and a median observation time of 72.3 months [lower quartile (LQ) 58.1; upper quartile (UQ) 82.8] have been included. DTCs were detected via immunohistochemistry as MUC-1 positive cells in the BM of 59.13 % (298 of 504) of the patients. The immunophenotyping of cancer cells was achieved immunohistochemically as well.ResultsFor luminal A/B carcinoma patients, we observed a significant benefit of BM DTC negativity with respect to DFS (luminal A, P = 0.0498; luminal B, P = 0.0224). In triple-negative patients, DTC-negative BM was associated with a longer OS (P = 0.0326). In a multivariate Cox survival analysis relating to DFS and OS, the DTC status was identified as an independent prognostic factor for DFS in luminal A/B BC (P = 0.0071). A multivariate Cox survival analysis among DTC-positive patients with luminal immunophenotype showed bisphosphonate application (P = 0.0326) to be an independent prognostic factor for DFS.ConclusionsThe findings of our multivariate analyses reveal BM DTC positivity as an independent risk factor for DFS particularly in luminal A/B BC patients. This might be a novel criterion for the identification of candidates most likely to benefit from additional adjuvant therapy possibly including bisphosphonates. 
650 4 |a Bisphosphonate Treatment 
650 4 |a Breast Cancer 
650 4 |a Disseminate Tumor Cell 
650 4 |a Overall Survival 
650 4 |a Primary Breast Cancer Patient 
700 1 |a Diel, Ingo J.  |d 1950-  |e VerfasserIn  |0 (DE-588)113615329  |0 (DE-627)522671934  |0 (DE-576)289768527  |4 aut 
700 1 |a Sinn, Peter  |d 1957-  |e VerfasserIn  |0 (DE-588)1022590944  |0 (DE-627)717004783  |0 (DE-576)365646342  |4 aut 
700 1 |a Englert, Stefan  |d 1986-  |e VerfasserIn  |0 (DE-588)1037466241  |0 (DE-627)755789539  |0 (DE-576)391501917  |4 aut 
700 1 |a Hennigs, André  |e VerfasserIn  |0 (DE-588)1077795238  |0 (DE-627)837512395  |0 (DE-576)446682780  |4 aut 
700 1 |a Mayer, Christine  |d 1982-  |e VerfasserIn  |0 (DE-588)136998585  |0 (DE-627)589003909  |0 (DE-576)301383308  |4 aut 
700 1 |a Schott, Sarah  |d 1981-  |e VerfasserIn  |0 (DE-588)133730816  |0 (DE-627)552697281  |0 (DE-576)27460678X  |4 aut 
700 1 |a Wallwiener, Markus  |d 1980-  |e VerfasserIn  |0 (DE-588)134044827  |0 (DE-627)692043934  |0 (DE-576)27468327X  |4 aut 
700 1 |a Blumenstein, Maria  |d 1973-  |e VerfasserIn  |0 (DE-588)137640757  |0 (DE-627)594509084  |0 (DE-576)303750642  |4 aut 
700 1 |a Golatta, Michael  |d 1974-  |e VerfasserIn  |0 (DE-588)132350386  |0 (DE-627)521535727  |0 (DE-576)299091392  |4 aut 
700 1 |a Heil, Jörg  |d 1978-  |e VerfasserIn  |0 (DE-588)132580187  |0 (DE-627)52396160X  |0 (DE-576)299238679  |4 aut 
700 1 |a Rom, Joachim  |d 1975-  |e VerfasserIn  |0 (DE-588)130877018  |0 (DE-627)707590604  |0 (DE-576)298390833  |4 aut 
700 1 |a Sohn, Christof  |d 1961-  |e VerfasserIn  |0 (DE-588)131349287  |0 (DE-627)507642902  |0 (DE-576)298422255  |4 aut 
700 1 |a Schneeweiss, Andreas  |d 1961-  |e VerfasserIn  |0 (DE-588)109972554  |0 (DE-627)632849630  |0 (DE-576)327251859  |4 aut 
700 1 |a Schütz, Florian  |d 1972-  |e VerfasserIn  |0 (DE-588)12303387X  |0 (DE-627)082307229  |0 (DE-576)293528810  |4 aut 
700 1 |a Domschke, Christoph  |d 1982-  |e VerfasserIn  |0 (DE-588)139103201  |0 (DE-627)703207679  |0 (DE-576)310245095  |4 aut 
773 0 8 |i Enthalten in  |t Annals of surgical oncology  |d Berlin [u.a.] : Springer, 1994  |g 23(2016), 3, Seite 757-766  |h Online-Ressource  |w (DE-627)343969947  |w (DE-600)2074021-9  |w (DE-576)099879212  |x 1534-4681  |7 nnas  |a Disseminated tumor cells in the bone marrow of patients with operable primary breast cancer prognostic impact in immunophenotypic subgroups and clinical implication for bisphosphonate treatment 
773 1 8 |g volume:23  |g year:2016  |g number:3  |g pages:757-766  |g extent:10  |a Disseminated tumor cells in the bone marrow of patients with operable primary breast cancer prognostic impact in immunophenotypic subgroups and clinical implication for bisphosphonate treatment 
856 4 0 |u https://doi.org/10.1245/s10434-015-4895-3  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20190522 
993 |a Article 
994 |a 2016 
998 |g 139103201  |a Domschke, Christoph  |m 139103201:Domschke, Christoph  |d 910000  |d 910400  |e 910000PD139103201  |e 910400PD139103201  |k 0/910000/  |k 1/910000/910400/  |p 16  |y j 
998 |g 12303387X  |a Schütz, Florian  |m 12303387X:Schütz, Florian  |d 910000  |d 910400  |e 910000PS12303387X  |e 910400PS12303387X  |k 0/910000/  |k 1/910000/910400/  |p 15 
998 |g 109972554  |a Schneeweiss, Andreas  |m 109972554:Schneeweiss, Andreas  |d 910000  |d 910400  |e 910000PS109972554  |e 910400PS109972554  |k 0/910000/  |k 1/910000/910400/  |p 14 
998 |g 131349287  |a Sohn, Christof  |m 131349287:Sohn, Christof  |d 910000  |d 910400  |e 910000PS131349287  |e 910400PS131349287  |k 0/910000/  |k 1/910000/910400/  |p 13 
998 |g 130877018  |a Rom, Joachim  |m 130877018:Rom, Joachim  |d 910000  |d 910400  |e 910000PR130877018  |e 910400PR130877018  |k 0/910000/  |k 1/910000/910400/  |p 12 
998 |g 132580187  |a Heil, Jörg  |m 132580187:Heil, Jörg  |d 910000  |d 910400  |e 910000PH132580187  |e 910400PH132580187  |k 0/910000/  |k 1/910000/910400/  |p 11 
998 |g 132350386  |a Golatta, Michael  |m 132350386:Golatta, Michael  |d 910000  |d 910400  |e 910000PG132350386  |e 910400PG132350386  |k 0/910000/  |k 1/910000/910400/  |p 10 
998 |g 137640757  |a Blumenstein, Maria  |m 137640757:Blumenstein, Maria  |d 910000  |d 910400  |e 910000PB137640757  |e 910400PB137640757  |k 0/910000/  |k 1/910000/910400/  |p 9 
998 |g 134044827  |a Wallwiener, Markus  |m 134044827:Wallwiener, Markus  |d 910000  |d 910400  |e 910000PW134044827  |e 910400PW134044827  |k 0/910000/  |k 1/910000/910400/  |p 8 
998 |g 133730816  |a Schott, Sarah  |m 133730816:Schott, Sarah  |d 910000  |d 910400  |e 910000PS133730816  |e 910400PS133730816  |k 0/910000/  |k 1/910000/910400/  |p 7 
998 |g 136998585  |a Mayer, Christine  |m 136998585:Mayer, Christine  |d 910000  |d 910400  |e 910000PM136998585  |e 910400PM136998585  |k 0/910000/  |k 1/910000/910400/  |p 6 
998 |g 1077795238  |a Hennigs, André  |m 1077795238:Hennigs, André  |d 910000  |d 910400  |e 910000PH1077795238  |e 910400PH1077795238  |k 0/910000/  |k 1/910000/910400/  |p 5 
998 |g 1037466241  |a Englert, Stefan  |m 1037466241:Englert, Stefan  |p 4 
998 |g 1022590944  |a Sinn, Peter  |m 1022590944:Sinn, Peter  |d 910000  |d 912000  |e 910000PS1022590944  |e 912000PS1022590944  |k 0/910000/  |k 1/910000/912000/  |p 3 
998 |g 111256117X  |a Stefanovic, Stefan  |m 111256117X:Stefanovic, Stefan  |d 910000  |d 910400  |e 910000PS111256117X  |e 910400PS111256117X  |k 0/910000/  |k 1/910000/910400/  |p 1  |x j 
999 |a KXP-PPN1666139009  |e 3478933846 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"origin":[{"publisher":"Springer ; Lippincott Williams & Wilkins","dateIssuedDisp":"1994-","dateIssuedKey":"1994","publisherPlace":"Berlin [u.a.] ; Philadelphia, Pa."}],"corporate":[{"role":"isb","display":"Society of Surgical Oncology"}],"title":[{"title_sort":"Annals of surgical oncology","subtitle":"the official journal of the Society of Surgical Oncology","title":"Annals of surgical oncology"}],"id":{"zdb":["2074021-9"],"issn":["1534-4681"],"eki":["343969947"]},"part":{"year":"2016","pages":"757-766","volume":"23","text":"23(2016), 3, Seite 757-766","extent":"10","issue":"3"},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 26.09.25"],"disp":"Disseminated tumor cells in the bone marrow of patients with operable primary breast cancer prognostic impact in immunophenotypic subgroups and clinical implication for bisphosphonate treatmentAnnals of surgical oncology","recId":"343969947","language":["eng"],"pubHistory":["1.1994 -"],"type":{"media":"Online-Ressource","bibl":"periodical"}}],"note":["First online: 14 October 2015","Gesehen am 22.05.2019"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1666139009"],"doi":["10.1245/s10434-015-4895-3"]},"physDesc":[{"extent":"10 S."}],"language":["eng"],"title":[{"title_sort":"Disseminated tumor cells in the bone marrow of patients with operable primary breast cancer","subtitle":"prognostic impact in immunophenotypic subgroups and clinical implication for bisphosphonate treatment","title":"Disseminated tumor cells in the bone marrow of patients with operable primary breast cancer"}],"recId":"1666139009","origin":[{"dateIssuedDisp":"2016","dateIssuedKey":"2016"}],"name":{"displayForm":["Stefan Stefanovic, MD, Ingo Diel, MD, Peter Sinn, MD, Stefan Englert, PhD, Andre Hennigs, MD, Christine Mayer, MD, Sarah Schott, MD, Markus Wallwiener, MD, Maria Blumenstein, MD, Michael Golatta, MD, Joerg Heil, MD, Joachim Rom, MD, Christof Sohn, MD, Andreas Schneeweiss, MD, Florian Schuetz, MD, and Christoph Domschke, MD"]},"person":[{"given":"Stefan","display":"Stefanovic, Stefan","family":"Stefanovic","role":"aut"},{"role":"aut","display":"Diel, Ingo J.","given":"Ingo J.","family":"Diel"},{"given":"Peter","display":"Sinn, Peter","family":"Sinn","role":"aut"},{"role":"aut","family":"Englert","given":"Stefan","display":"Englert, Stefan"},{"family":"Hennigs","display":"Hennigs, André","given":"André","role":"aut"},{"role":"aut","family":"Mayer","display":"Mayer, Christine","given":"Christine"},{"given":"Sarah","display":"Schott, Sarah","family":"Schott","role":"aut"},{"display":"Wallwiener, Markus","given":"Markus","family":"Wallwiener","role":"aut"},{"family":"Blumenstein","display":"Blumenstein, Maria","given":"Maria","role":"aut"},{"role":"aut","given":"Michael","display":"Golatta, Michael","family":"Golatta"},{"display":"Heil, Jörg","given":"Jörg","family":"Heil","role":"aut"},{"role":"aut","family":"Rom","given":"Joachim","display":"Rom, Joachim"},{"role":"aut","given":"Christof","display":"Sohn, Christof","family":"Sohn"},{"role":"aut","given":"Andreas","display":"Schneeweiss, Andreas","family":"Schneeweiss"},{"role":"aut","family":"Schütz","display":"Schütz, Florian","given":"Florian"},{"family":"Domschke","display":"Domschke, Christoph","given":"Christoph","role":"aut"}]} 
SRT |a STEFANOVICDISSEMINAT2016